SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-14-003765
Filing Date
2014-08-07
Accepted
2014-08-07 09:00:46
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1401457_10q.htm 10-Q 287191
2 EXHIBIT 31.1 t1401457_ex31-1.htm EX-31.1 8950
3 EXHIBIT 32.1 t1401457_ex32-1.htm EX-32.1 5404
  Complete submission text file 0001571049-14-003765.txt   3638064

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE mrna-20130331.xml EX-101.INS 502317
5 XBRL SCHEMA FILE mrna-20130331.xsd EX-101.SCH 43026
6 XBRL CALCULATION FILE mrna-20130331_cal.xml EX-101.CAL 32654
7 XBRL DEFINITION FILE mrna-20130331_def.xml EX-101.DEF 130594
8 XBRL LABEL FILE mrna-20130331_lab.xml EX-101.LAB 339324
9 XBRL PRESENTATION FILE mrna-20130331_pre.xml EX-101.PRE 238006
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 141021960
SIC: 2834 Pharmaceutical Preparations